A Tweet in response to FDA's approval of Aduhelm....

Bob Herman
@bobjherman
·
9m
Jaw on the floor: Biogen is charging a list price of $56,000 ($4,300 per infusion) for Aduhelm, a drug that *has not been proven to work*.